EXCEL-Punjabi: A Culturally Tailored Exercise Oncology Pilot Feasibility Intervention (EXCEL-Punjabi)
8 juni 2026 uppdaterad av: University of Calgary
EXCEL-Punjabi: Tailored Exercise Oncology for the South Asian Population
The goal of this pilot feasibility study is to explore the feasibility and exploratory effects of a culturally-tailored exercise oncology intervention in Punjabi-speaking individuals of South Asian heritage and their support persons. The main questions it aims to answer are:
- What is the feasibility and acceptability of the EXCEL-Punjabi intervention?
- What are the exploratory effects (i.e., psychosocial and physical changes) before and after program delivery?
Participants will take part in a 12-week exercise oncology intervention consisting of twice weekly hour long multimodal circuit-based exercise sessions. They will also complete questionnaires and functional fitness assessments pre- and post- intervention.
Studieöversikt
Studietyp
Interventionell
Inskrivning (Faktisk)
12
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Alberta
-
Calgary, Alberta, Kanada, T2N 1N4
- Genesis Centre Calgary
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Ja
Beskrivning
Inclusion Criteria:
- Punjabi-speaking
- Self-identified as being of South Asian heritage
- over the age of 18
- pre-, post-, or currently receiving cancer treatment or a support person of an individual living with and beyond cancer
- cleared to participate in, at minimum, mild intensity exercise by a Clinical Exercise Physiologist
- Able to provide informed consent
Exclusion Criteria:
- under the age of 18
- not cleared to exercise by a Clinical Exercise Physiologist
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: EXCEL-Punjabi
Culturally Tailored Exercise Oncology Intervention
|
Culturally Tailored Exercise Oncology Intervention
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Measurement Completion
Tidsram: Baseline to the end of the intervention (12 weeks)
|
Participants who completed all pre- and post- questionnaires and functional assessments
|
Baseline to the end of the intervention (12 weeks)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Referrals
Tidsram: Baseline to end of intervention (12 weeks)
|
Number of participants referred to intervention
|
Baseline to end of intervention (12 weeks)
|
|
Consented
Tidsram: Recruitment to end of intervention (12 weeks)
|
Number of participants who consented to participate in the intervention
|
Recruitment to end of intervention (12 weeks)
|
|
Enrolled
Tidsram: Baseline (week 0)
|
Number of participants who enrolled (i.e. completed baseline assessments)
|
Baseline (week 0)
|
|
Attendance
Tidsram: Baseline to end of intervention (12 weeks)
|
Intervention Attendance
|
Baseline to end of intervention (12 weeks)
|
|
Adverse Events
Tidsram: Baseline to end of intervention (12 weeks)
|
Using the standardized Common Terminology Criteria for Adverse Events Version 6.0
|
Baseline to end of intervention (12 weeks)
|
|
Time Required to Deliver and Implement Intervention
Tidsram: From recruitment to end of intervention (12 weeks)
|
Time requirement to deliver intervention
|
From recruitment to end of intervention (12 weeks)
|
|
Physical Activity Level
Tidsram: Baseline to end of intervention (12 weeks)
|
The Godin Leisure Time Exercise Questionnaire is used to determine subjective levels of physical activity in each participant.
Participants report how many times per week they partake in mild, moderate, and/or strenuous exercise.
Higher scores indicate a more physically active lifestyle.
|
Baseline to end of intervention (12 weeks)
|
|
Cancer related symptoms
Tidsram: Baseline to end of intervention (12 weeks)
|
Change in Edmonton Symptom Assessment Scale - revised: cancer.
Scale is from 0-10, where 0 means the symptom is absent and 10 means the worst possible severity of the symptom is being experienced.
|
Baseline to end of intervention (12 weeks)
|
|
Health Related Quality of Life
Tidsram: Baseline to end of intervention (12 weeks)
|
Change in EuroQual - 5Dimensions (EQ-5D) tool - first section is a questionnaire; last section uses a scale from 0-100, where 0 means the worst health imaginable and 100 means the best health imaginable.
|
Baseline to end of intervention (12 weeks)
|
|
Fatigue
Tidsram: Baseline to end of intervention (12 weeks)
|
Change in Functional Assessment of Chronic Illness Therapy - Fatigue subscale - scale is from 0-4, where 0 means "not at all" and 4 means "very much".
|
Baseline to end of intervention (12 weeks)
|
|
Cancer Related Quality of Life
Tidsram: Baseline to end of intervention (12 weeks)
|
A 5-point Likert scale (0 = not at all, to 4 = very much) to track wellbeing over the course of the cancer journey.
|
Baseline to end of intervention (12 weeks)
|
|
Exercise Barriers Self-Efficacy
Tidsram: Baseline to end of intervention (12 weeks)
|
Exercise barriers and facilitators questionnaire
|
Baseline to end of intervention (12 weeks)
|
|
Cognition
Tidsram: Baseline to end of intervention (12 weeks)
|
Cancer related cognition using the Functional Assessment of Cancer Therapy - Cognition questionnaire.
A 37-item, self-report questionnaire used to evaluate how cancer patients perceive their own cognitive abilities
|
Baseline to end of intervention (12 weeks)
|
|
Aerobic Capacity
Tidsram: Baseline to end of intervention (12 weeks)
|
In-person participants will be assessed on change in 6-minute walk test (m) results
|
Baseline to end of intervention (12 weeks)
|
|
Aerobic Capacity
Tidsram: Baseline to end of intervention (12 weeks)
|
Online participants will be assessed with change in the 2-minute step test (number of steps) results.
|
Baseline to end of intervention (12 weeks)
|
|
Lower body strength
Tidsram: Baseline to end of intervention (12 weeks)
|
Change in sit-to-stand (number of repetitions in 30 seconds)
|
Baseline to end of intervention (12 weeks)
|
|
Upper extremity flexibility
Tidsram: Baseline to end of intervention (12 weeks)
|
Change in active shoulder flexion range of motion (degrees)
|
Baseline to end of intervention (12 weeks)
|
|
Balance
Tidsram: Baseline to end of intervention (12 weeks)
|
Change in one legged stance test (seconds)
|
Baseline to end of intervention (12 weeks)
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Allmänna publikationer
- Cheifetz O, Park Dorsay J, Hladysh G, Macdermid J, Serediuk F, Woodhouse LJ. CanWell: meeting the psychosocial and exercise needs of cancer survivors by translating evidence into practice. Psychooncology. 2014 Feb;23(2):204-15. doi: 10.1002/pon.3389. Epub 2013 Sep 6.
- Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390. doi: 10.1249/MSS.0000000000002116.
- Cormie P, Zopf EM, Zhang X, Schmitz KH. The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects. Epidemiol Rev. 2017 Jan 1;39(1):71-92. doi: 10.1093/epirev/mxx007.
- McNeely ML, Sellar C, Williamson T, Shea-Budgell M, Joy AA, Lau HY, Easaw JC, Murtha AD, Vallance J, Courneya K, Mackey JR, Parliament M, Culos-Reed N. Community-based exercise for health promotion and secondary cancer prevention in Canada: protocol for a hybrid effectiveness-implementation study. BMJ Open. 2019 Sep 13;9(9):e029975. doi: 10.1136/bmjopen-2019-029975.
- King-Shier K, Lau A, Fung S, LeBlanc P, Johal S. Ethnocultural influences in how people prefer to obtain and receive health information. J Clin Nurs. 2018 Apr;27(7-8):e1519-e1528. doi: 10.1111/jocn.14281. Epub 2018 Mar 30.
- Loeb S, Borno HT, Gomez S, Ravenell J, Myrie A, Sanchez Nolasco T, Byrne N, Cole R, Black K, Stair S, Macaluso JN, Walter D, Siu K, Samuels C, Kazemi A, Crocker R, Sherman R, Wilson G, Griffith DM, Langford AT. Representation in Online Prostate Cancer Content Lacks Racial and Ethnic Diversity: Implications for Black and Latinx Men. J Urol. 2022 Mar;207(3):559-564. doi: 10.1097/JU.0000000000002257. Epub 2022 Feb 4.
- Bhandari D, Ozaki A, Kobashi Y, Higuchi A, Shakya P, Tanimoto T. Cancer information seeking and scanning behavior among Nepalese migrants in Japan and its association with preventive behavior. PLoS One. 2020 Jun 29;15(6):e0235275. doi: 10.1371/journal.pone.0235275. eCollection 2020.
- Caperchione CM, Chau S, Walker GJ, Mummery WK, Jennings C. Gender-Associated Perceptions of Barriers and Motivators to Physical Activity Participation in South Asian Punjabis Living in Western Canada. J Phys Act Health. 2015 May;12(5):686-93. doi: 10.1123/jpah.2013-0208. Epub 2013 Aug 7.
- Wagoner CW, Dreger J, Keats MR, Santa Mina D, McNeely ML, Cuthbert C, Capozzi LC, Francis GJ, Trinh L, Sibley D, Langley J, Chiekwe J, Ester M, Foucaut AM, Culos-Reed SN. First-Year Implementation of the EXercise for Cancer to Enhance Living Well (EXCEL) Study: Building Networks to Support Rural and Remote Community Access to Exercise Oncology Resources. Int J Environ Res Public Health. 2023 Jan 20;20(3):1930. doi: 10.3390/ijerph20031930.
- Heston AH, Schwartz AL, Justice-Gardiner H, Hohman KH. Addressing physical activity needs of survivors by developing a community-based exercise program: LIVESTRONG(R) at the YMCA. Clin J Oncol Nurs. 2015 Apr;19(2):213-7. doi: 10.1188/15.CJON.213-217.
- Haas BK, Kimmel G, Hermanns M, Deal B. Community-based FitSTEPS for life exercise program for persons with cancer: 5-year evaluation. J Oncol Pract. 2012 Nov;8(6):320-4, 2 p following 324. doi: 10.1200/JOP.2012.000555. Epub 2012 Jul 24.
- Leach HJ, Danyluk JM, Nishimura KC, Culos-Reed SN. Evaluation of a Community-Based Exercise Program for Breast Cancer Patients Undergoing Treatment. Cancer Nurs. 2015 Nov-Dec;38(6):417-25. doi: 10.1097/NCC.0000000000000217.
- Leach HJ, Danyluk JM, Culos-Reed SN. Design and implementation of a community-based exercise program for breast cancer patients. Curr Oncol. 2014 Oct;21(5):267-71. doi: 10.3747/co.21.2079.
- Culos-Reed N, Wagoner CW, Dreger J, McNeely ML, Keats M, Santa Mina D, Cuthbert C, Capozzi LC, Francis GJ, Chen G, Ester M, McLaughlin E, Eisele M, Sibley D, Langley J, Chiekwe J, Christensen T; EXCEL Project Team. Implementing an exercise oncology model to reach rural and remote individuals living with and beyond cancer: a hybrid effectiveness-implementation protocol for project EXCEL (EXercise for Cancer to Enhance Living Well). BMJ Open. 2022 Dec 29;12(12):e063953. doi: 10.1136/bmjopen-2022-063953.
- Hardcastle SJ, Cohen PA. Effective Physical Activity Promotion to Survivors of Cancer Is Likely to Be Home Based and to Require Oncologist Participation. J Clin Oncol. 2017 Nov 10;35(32):3635-3637. doi: 10.1200/JCO.2017.74.6032. Epub 2017 Sep 15. No abstract available.
- Bansal M, Rana B, Ghotra H, King-Shier K, Bridel W, Culos-Reed SN. Exploring physical activity experiences, barriers, and facilitators among individuals of South Asian heritage living with and beyond cancer. Ethn Health. 2023 Nov;28(8):1085-1102. doi: 10.1080/13557858.2023.2224951. Epub 2023 Jun 14.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
1 juli 2025
Primärt slutförande (Faktisk)
12 december 2025
Avslutad studie (Faktisk)
12 december 2025
Studieregistreringsdatum
Först inskickad
11 maj 2026
Först inskickad som uppfyllde QC-kriterierna
8 juni 2026
Första postat (Faktisk)
11 juni 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
11 juni 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
8 juni 2026
Senast verifierad
1 maj 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- HREBA.CC-25-0150
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
IPD-planbeskrivning
Aggregate and participant-level results are reported within publications, but there is no formal plan for external IPD sharing.
With a small sample size from a specific cultural group, there may be risk of re-identification.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .